Levofloxacin aldolase thiosemicarbazide derivative and preparation method and application thereof
A technology of levofloxacin aldehyde amino reduction and star aldehyde amino reduction, which is applied in the field of new drug discovery and innovative drug synthesis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0046] (S)-6-fluoro-7-(4-methyl-piperazin-1-yl)-1,8-(2,1-oxypropyl)-quinoline-4(1H)-one-3- Aldehyde thiosemicarbazone (I-1), its chemical structure is:
[0047]
[0048] That is, R in formula I is a H atom.
[0049] The preparation method of the compound is as follows: take the crude levofloxacin aldehyde represented by formula (IV) (1.0g) and dissolve it in absolute ethanol (20ml), add thiosemicarbazide (0.5g, 5.5mmol), reflux and react for 12 hours, while hot After filtration, the solid was washed twice with ethanol, washed twice with distilled water, dried, and recrystallized with DMF-ethanol (V:V=5:3) mixed solvent to obtain light yellow crystals of formula (I-1) to obtain the product 0.48g, mp231~233℃. 1 H NMR(400MHz, DMSO-d 6 )δ: 11.43(s,1H,CH=N),8.76(s,1H,2-H), 8.44(s,1H,NH),8.36(s,1H,NH 2 ),8.33(s,1H,NH 2 ),7.47(d,1H,5-H), 4.62~4.34(m,3H, OCH 2 CHN), 3.24(t,4H, piperazine-H), 2.55(t,4H, piperazine-H), 2.26(s,3H, N-CH 3 ), 1.45(d,3H,CH 3 ); MS(m / z): Calcd.for C 19 H 23 FN 6...
Embodiment 2
[0051] (S)-6-fluoro-7-(4-methyl-piperazin-1-yl)-1,8-(2,1-oxypropyl)-quinoline-4(1H)-one-3- Aldehyde 4-methylthiosemicarbazide (I-2), its chemical structure is:
[0052]
[0053] That is, R in formula I is a methyl group.
[0054] The preparation method of this compound is as follows: Take the levofloxacin aldehyde hydrazinodithioformate methyl ester (1.0g, 2.23mmol) represented by formula (VI) and dissolve it in anhydrous n-butanol (20ml), add methylamine ( 0.68g, 22.0mmol), the mixed reactants were refluxed and reacted for 12 hours, filtered while hot, and the solids were washed twice with ethanol, washed with distilled water twice, dried, and re-weighted with DMF-ethanol (V:V=1:5) mixed solvent Crystallize to obtain 0.33 g of the product of formula (I-2) as yellow crystals, mp 210-212°C. 1 H NMR(400MHz, DMSO-d 6 )δ: 11.46(s,1H,CH=N),8.77(s,1H,2-H), 8.36(s,1H,NH),8.35(s,1H,NH),7.46(d,1H,5 -H), 4.57~4.32(m,3H, OCH 2 CHN), 3.24(t,4H, piperazine-H), 3.12(d,3H,NH-CH 3 ), 2.47(t,4H, ...
Embodiment 3
[0056] (S)-6-fluoro-7-(4-methyl-piperazin-1-yl)-1,8-(2,1-oxypropyl)-quinoline-4(1H)-one-3- Aldehyde 4-ethylthiosemicarbazide (I-3), its chemical structure is:
[0057]
[0058] That is, R in formula I is ethyl.
[0059] The preparation method of the compound is as follows: take the levofloxacin aldehyde hydrazinodithioformate methyl ester (1.0g, 2.23mmol) represented by formula (VI) and dissolve it in anhydrous n-butanol (20ml), add ethylamine ( 0.90g, 20.0mmol), the mixed reactants were refluxed and reacted for 12 hours, filtered while hot, and the solids were washed twice with ethanol, washed with distilled water twice, dried, and weighed with DMF-ethanol (V:V=1:5) mixed solvent After crystallization, 0.48g of yellow crystalline product of formula (I-3) was obtained, mp204~206℃. 1 H NMR(400MHz, DMSO-d 6 )δ: 11.42(s,1H,CH=N),8.77(s,1H,2-H), 8.43(d,1H,NH),8.33(s,1H,NH),7.42(d,1H,5 -H), 4.57~4.33(m,3H, OCH 2 CHN), 3.58(m,2H,CH 2 ), 3.24(t,4H, piperazine-H), 2.46(t,4H, piperazine-H...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com